A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor.

Jeffrey S. Rubin, Andrew M. Chan, Donald P. Bottaro, W H Burgess, W Taylor, ALEX C. CECH, David W. Hirschfield, Joel Wong, T Miki, Paul W. Finch

Proceedings of the National Academy of Sciences · 1991 · 502 citations · 26 references

Concepts

Abstract

A heparin-binding mitogen was isolated from conditioned medium of human embryonic lung fibroblasts. It exhibited broad target-cell specificity whose pattern was distinct from that of any known growth factor. It rapidly stimulated tyrosine phosphorylation of a 145-kDa protein in responsive cells, suggesting that its signaling pathways involved activation of a tyrosine kinase. Purification identified a major polypeptide with an apparent molecular mass of 87 kDa under reducing conditions. Partial amino acid sequence analysis and cDNA cloning revealed that it was a variant of hepatocyte growth factor, a mitogen thought to be specific for hepatic cells and structurally related to plasminogen. Recombinant expression of the cDNA in COS-1 cells established that it encoded the purified growth factor. Its site of synthesis and spectrum of targets imply that this growth factor may play an important role as a paracrine mediator of the proliferation of melanocytes and endothelial cells, as well as cells of epithelial origin.

References

26